Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2007 (Vol. 27, No. 4)

HIV Molecular Immunology Database

URL:www.hiv.lanl.gov/content/immunology/index.html
  • Lots of info
  • Limited search functions
Like the NIH, the Los Alamos National Laboratory (LANL) hosts numerous useful sites that have few peers. With data extracted from HIV immunology literature, the HIV Molecular Immunology Database provides links to related LANL databases covering sequences, resistance, and vaccine trials. Access to information is on the nerdy side of the spectrum. A section entitled Search Help runs on and on. The primary access appears to be a single text box for searching with no options for restricting or specifying search parameters. On the plus side, I was able to enter common words, like “map”, and get back a set of links to useful maps. The inability of users to restrict searches is an unfortunate omission that I hope will get corrected in a future version. Meanwhile, there is a lot of info here, so the site is worth checking out.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »